InvestorsHub Logo
Followers 300
Posts 33477
Boards Moderated 2
Alias Born 08/07/2004

Re: $toney post# 14868

Thursday, 06/28/2012 8:28:03 PM

Thursday, June 28, 2012 8:28:03 PM

Post# of 20496
OREX has been good for a trade ...

but contrave, IMO isnt going to be a big factor here for weight loss...its a combo of 2 already existing drugs, and neither of them were developed for weight loss initially..just like qnexa which is topiramate/phentermine

bupropion/naltrexone ..is contrave

Contrave causes an increase in blood pressure and heart rate, which is especially dangerous for obese people. Now, Orexigen is conducting a cardiovascular outcomes trial for


On the other hand, the development of lorcaserin by ARNA was specifically designed just to target the appetite receptor..specifically designed for weight loss

Personally im not touting anything here..I made my money and am out...

But the info is clear, that Lorq with the phentermine combo, will take control of the majority of the market.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.